Study Comparing High and Low Potassium Fruit and Vegetable Diets in Adults With Chronic Kidney Disease to See Effects on Blood Potassium Levels and Quality of Life
Led by University of Manitoba · Updated on 2026-01-16
30
Participants Needed
2
Research Sites
N/A
Total Duration
AI-Summary
What this Trial Is About
Researchers are investigating how the potassium content in fruits and vegetables affects blood potassium levels in people with Chronic Kidney Disease CKD. The study aims to provide high-quality evidence to guide dietary potassium recommendations, which currently rely on low-quality data. This research also explores whether a diet higher in potassium from fruits and vegetables might improve quality of life for people with CKD.
In this 16-week randomized crossover trial, participants will receive deliveries of fruits and vegetables with either higher or lower potassium content in a random order. Each treatment period lasts 6 weeks, separated by a 2-week washout period. During each period, participants will have a dietary counseling session with a registered dietitian to help incorporate the assigned fruits and vegetables into their regular diet. The potassium-rich foods will aim for about 2000 mg of potassium daily from the delivered produce, while the lower potassium foods will provide less than 500 mg daily.
Participants will be monitored throughout the trial with blood and urine tests to measure potassium and other markers, blood pressure checks, and assessments of physical function using a chair stand test. Quality of life related to physical function will also be evaluated. The main outcome is the change in blood potassium levels between the two treatment periods. This study will last about 16 weeks and may influence future dietary advice for people with CKD regarding potassium intake.
CONDITIONS
Brief Title
Dietary Potassium Liberalization in Pre-Dialysis Patients
Research Team
D
Dylan Mackay, PhD
R
Rebecca Mollard, PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
New York Heart Association Class 3-4 heart symptoms or heart, liver, or renal transplant
Myocardial infarction or stroke within the last 6 months
Unable to consume study treatments due to swallowing or gastrointestinal issues
Currently taking potassium binding therapy
Any medical condition or uncontrolled disease that reduces study compliance or participant safety
Female participants who are pregnant or breastfeeding
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Run-in Period
Duration - 2 weeks
Participants receive a 2-week run-in period with liberalized dietary potassium via fruit and vegetables delivered to their homes. A dietary counseling session with a registered dietitian is provided to explain the intervention and recommend preparation methods.
1 counseling session (in-person or videoconference)
Treatment
Duration - 14 weeks
Participants receive 6 weeks of one dietary potassium intervention (either liberalized or restricted potassium fruit and vegetable delivery), followed by a 2-week washout period, then cross over to 6 weeks of the alternate dietary intervention. Each treatment period includes a dietary counseling session with a registered dietitian.
Weekly visits for 14 weeks including grocery deliveries and 2 counseling sessions (in-person or videoconference)
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
CROSSOVER
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Randomized Trial Comparing Physical Therapy During Versus Before Hemodialysis in Adults With End-Stage Renal Disease
Study Investigating Metabolism and Body Size in Healthy Individuals and Those with Metabolic Conditions
Phase III Study of HRS-1780 Tablets for Adults With Chronic Kidney Disease to Slow Kidney Function Decline
A Multicenter Observational Study of Treatment and Outcomes in Chinese Adults with Chronic Kidney Disease
A Large-Scale Observational Study on Chronic Kidney Disease and Related Risk Factors in China
Study of Weekly NNC0519-0130 Injections Compared to Semaglutide and Placebo for Kidney Health in Adults with Chronic Kidney Disease and Overweight or Obesity
Using a Smartphone App to Help Young Adults with Chronic Kidney Disease Follow the 2024 KDIGO Care Guidelines
Trial to Improve Decision-Making Support for Adults with Stage 4 Chronic Kidney Disease and Their Caregivers Using a Telehealth Intervention
Phase 2 Trial of Luspatercept Injection for Adults with Anemia Due to Chronic Kidney Disease
Phase 1 Study on Safety and Effects of ONO-3310 Oral Doses in Healthy Japanese Adult Males and Chronic Kidney Disease Patients with Type 2 Diabetes
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Dietary potassium liberalization with fruit and vegetables versus potassium restriction in people with chronic kidney disease (DK-Lib CKD): a clinical trial protocol.